Back
EyePoint Pharmaceuticals Stock Price Chart
This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
41
EYPT
EyePoint Pharmaceuticals
Last Price:
$5.87
Seasonality Move:
4.94%
7 Day Trial
ALL ACCESS PASS
$
7
Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.9 | Buy |
| 20-day SMA: | 6.34 | Sell |
| 50-day SMA: | 6.01 | Buy |
| 200-day SMA: | 7.85 | Sell |
| 8-day EMA: | 6.05 | Buy |
| 20-day EMA: | 6.1 | Buy |
| 50-day EMA: | 6.19 | Buy |
| 200-day EMA: | 8.06 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 51.9 | Buy |
| Chaikin Money Flow: | 347663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.75 - 6.73) | Sell |
| Bollinger Bands (100): | (5.59 - 7.65) | Sell |
EyePoint Pharmaceuticals Technical Analysis
| May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 6.21 while EYPT 8-day simple moving average is 5.90, which is a Buy signal.
-
The stock price of EYPT is 6.21 while EyePoint Pharmaceuticals 20-day SMA is 6.34, which makes it a Sell.
-
EyePoint Pharmaceuticals 50-day simple moving average is 6.01 while EYPT share price is 6.21, making it a Buy technically.
-
EYPT stock price is 6.21 and EyePoint Pharmaceuticals 200-day simple moving average is 7.85, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Sell
41
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a SellThe current EyePoint Pharmaceuticals [EYPT] share price is $6.21. The Score for EYPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
427.3M
Price in USD:
6.21
Share Volume:
695.3K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
13.99
52-Week Low:
3.91
Sell
41
EyePoint Pharmaceuticals (EYPT)
is a Sell
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?The EyePoint Pharmaceuticals stock price is 6.21 USD today.
-
Will EYPT stock go up or go down?EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is EyePoint Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 6.21 while EYPT 8-day exponential moving average is 6.05, which is a Buy signal.
-
The stock price of EYPT is 6.21 while EyePoint Pharmaceuticals 20-day EMA is 6.10, which makes it a Buy.
-
EyePoint Pharmaceuticals 50-day exponential moving average is 6.19 while EYPT share price is 6.21, making it a Buy technically.
-
EYPT stock price is 6.21 and EyePoint Pharmaceuticals 200-day simple moving average is 8.06, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.09 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
-
EYPT Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting EyePoint Pharmaceuticals is a Sell
-
EyePoint Pharmaceuticals Relative Strength Index (RSI) is 51.9, which suggest EyePoint Pharmaceuticals is overbought
-
The Bollinger Bands (25) for EyePoint Pharmaceuticals is (5.75 - 6.73), which suggest EyePoint Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for EyePoint Pharmaceuticals is (5.59 - 7.65), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.